MillerKnoll (MLKN) has reported its FY 2026 results with fourth quarter revenue of US$1,004.2 million and basic EPS of US$0.34, supported by trailing twelve month revenue of US$3.8 billion and EPS of US$1.33. Over recent periods, the company has seen quarterly revenue move from US$876.2 million in FY 2025 Q3 to US$1,004.2 million in FY 2026 Q4, while quarterly EPS has ranged from a loss of US$0.84 in FY 2025 Q4 to a profit of US$0.34 in FY 2026 Q4. This provides a basis for investors to focus...
Over the last 7 days, the United States market has experienced a 2.7% decline, yet it remains up by 19% over the past year with earnings projected to grow by 18% annually. In this dynamic environment, identifying promising small-cap stocks that are perceived as undervalued and exhibit insider activity can offer intriguing opportunities for investors seeking potential growth.
Over the last 7 days, the United States market has dropped 2.7%, yet it remains up by 19% over the past year, with earnings forecasted to grow by 18% annually. In this environment, identifying high growth tech stocks involves looking for companies that not only show strong potential for revenue growth but also demonstrate resilience and adaptability in fluctuating market conditions.
Over the last 7 days, the United States market has experienced a 2.7% decline, yet it remains up by 19% over the past year with earnings projected to grow by 18% annually. In this fluctuating environment, companies that exhibit high growth potential and significant insider ownership can be particularly appealing as they often signal confidence from those who know the business best.
PTC Therapeutics (NasdaqGS:PTCT) has launched Sephience, its newly approved treatment for phenylketonuria, with early sales described as strong.
The company has completed a US$500 million convertible note offering to support future business development activity.
PTC Therapeutics is also working within an ongoing collaboration with Novartis that frames a broader period of change for the business.
For investors following rare disease drug developers, PTC Therapeutics sits at an interesting...
AI Infrastructure stocks sit at the crossroads of powerful themes: solid global demand for data, resilient consumer spending in markets like the US, and heavy investment in technology supply chains from hubs such as Hong Kong and Singapore. While inflation and interest rate paths still matter, many investors are looking for companies that turn AI demand into real-world cash flow through data centers, power, cooling, and connectivity. This AI Infrastructure Stocks screener narrows that...
Affirm Holdings partnered with outdoor retailer Backcountry to introduce flexible payment options for gear and apparel purchases.
The partnership extends across Backcountry’s family of outdoor and sports brands, covering a broad range of outdoor recreation shoppers.
The deal expands Affirm’s presence in the outdoor recreation category and adds another large merchant to its network.
Affirm Holdings, traded as NasdaqGS:AFRM, is moving further into the outdoor recreation space through this new...
Peace signals between the U.S. and Iran, extra IAEA oversight, and a toll free reopening of the Strait of Hormuz have shifted attention back to how quickly risk premiums can change in global energy markets. For investors watching large, financially solid oil and gas stocks in the U.S., UK, Canada, and Australia, this mix of easing tensions and lingering uncertainty could reshape how certain companies are priced. This article looks at 3 stocks from the Global Energy Sector screener that appear...
With tech stocks under pressure and investors shifting attention toward more defensive areas, some larger companies in utilities, consumer staples, and healthcare are drawing fresh interest. These businesses often serve everyday needs, so their revenues can sometimes be less tied to market swings or sudden changes in sentiment. This article looks at 3 stocks from a Defensive Stocks screener that appear closely exposed to the latest tech selloff, sector rotation, and volatility. The goal is to...
Tech stocks tied to AI have been hit from several directions recently, from a global sell off and steep drops in memory chipmakers to Apple warning on rising memory costs, even as Micron reports a sharp profit jump. For investors looking at the infrastructure behind AI and cloud growth, that kind of volatility can reshape expectations for data center REITs and related plays. This article explains how those headlines connect to the physical side of AI infrastructure and highlights 3 stocks...
Teamshares (TMS) stock recently attracted investor attention after its latest trading session, with shares closing at $10.70. The move comes as investors weigh the company’s employee-ownership focused acquisition model.
See our latest analysis for Teamshares.
Looking beyond the latest session, Teamshares’ share price return of 3.9% year to date, supported by a 2.9% 90 day share price return, suggests modest positive momentum, while the 1 year total shareholder return is flat.
If this employee...
These clinical-stage biotech stocks focused on Parkinson's research feature treatments already in human trials, where clinical milestones could turn into meaningful share price catalysts.
Geothermal energy is moving from niche concept to front-page topic, as fresh US legislation, new drilling technology and rising interest from big tech and venture funds put the sector in the spotlight. For investors, that mix of political backing, technical progress and still challenging project economics creates both potential openings and clear risks. This article looks at how the latest geothermal news could affect listed companies tied to the sector, and breaks down 3 stocks from our...
Open-source AI is putting real pressure on closed, premium models, and that tension is starting to show up in stock prices. As customers question high AI service costs and regulators scrutinize leading frontier labs, investors are asking which companies might benefit if budgets and trust shift toward open platforms. This article looks at how the recent open-source AI news may affect listed companies that mention open-source AI in their business descriptions, and reveals 3 stocks that appear...
